Dimethoxycurcumin Acidifies Endolysosomes and Inhibits SARS-CoV-2 Entry
The pandemic of coronavirus disease 2019 (COVID-19) caused by infection by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) continues to take a huge toll on global health. Although improving, currently there are only limited therapies against SARS-CoV-2. Curcumin, a natural polyphenol, e...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Virology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fviro.2022.923018/full |